Literature DB >> 14517592

Adrenoleukodystrophy initially diagnosed as idiopathic Addison's disease in two patients: the importance of early testing.

Wuh-Liang Hwu1, Yin-Hsiu Chien, Jao-Shwann Liang, Wang-Tso Lee, Peng-Jung Wang, Wen-Yu Tsai.   

Abstract

Childhood cerebral X-linked adrenoleukodystrophy (X-ALD) is a rare neurodegenerative disease typically presenting from age 4 to 8 years in males. We report 2 cases of X-ALD in boys. The diagnosis of Addison's disease was made before the development of neurological symptoms in both cases. The first patient had hyperpigmentation of the lips and an adrenocorticotropic hormone (ACTH) level higher than 1250 pg/mL when he was 7 years 3 months old. The initial diagnosis was Addison's disease, but X-ALD was diagnosed at age 8 years 8 months, when his motor and mental function deteriorated. The second boy had hypoglycemia, skin pigmentation, and an ACTH level of 1086 pg/mL when he was 4 years 6 months old, but the diagnosis was changed from Addison's disease to X-ALD owing to deterioration in speech at age 7 years. Since both bone marrow transplantation and Lorenzo's oil are beneficial only at the early stage of disease and idiopathic Addison's disease is very rare in children, it is important to test for very-long-chain fatty acids in boys suspected of having Addison's disease.

Entities:  

Mesh:

Year:  2003        PMID: 14517592

Source DB:  PubMed          Journal:  J Formos Med Assoc        ISSN: 0929-6646            Impact factor:   3.282


  2 in total

1.  Early diagnosis of cerebral X-linked adrenoleukodystrophy in boys with Addison's disease improves survival and neurological outcomes.

Authors:  Lynda E Polgreen; Saydi Chahla; Weston Miller; Steven Rothman; Jakub Tolar; Teresa Kivisto; David Nascene; Paul J Orchard; Anna Petryk
Journal:  Eur J Pediatr       Date:  2011-01-29       Impact factor: 3.183

2.  Clinical, biochemical, neuroimaging and molecular findings of X-linked Adrenoleukodystrophy patients in South China.

Authors:  Min-yan Jiang; Yan-na Cai; Cui-li Liang; Min-zhi Peng; Hui-ying Sheng; Li-ping Fan; Rui-zhu Lin; Hua Jiang; Yonglan Huang; Li Liu
Journal:  Metab Brain Dis       Date:  2015-08-12       Impact factor: 3.584

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.